Home
  • Networks
    • Small molecules

    • Cancer

    • Tissues

    • Cell lines
  • Analysis
    • Drug repurposing (CLUEreg)
    • Enrichment analysis
    • Upload your network
    • Network comparison
    • CCLE map
  • Help
    • GitHub
    • API
    • Changelog
    • Download
    • Contact
  • Changelog
    v0.1 cell line networks
    v0.2 aggregate tissue networks
    v0.3 TF enrichement tool
    v0.4 single-sample tissue networks
    v0.5 CLUEreg tool
    v0.6 colon cancer networks
    v0.7 drug networks
    v0.7.1 API v1
    v0.8 liver, cervix, and breast cancer networks
    v0.9 miRNA tissue networks
    v0.9.1 bootstrap 5
    v1.0 glioblastoma networks
    v1.0.1 drug combinations
    v1.1 Cell line networks
    v1.2 User upload network
    v1.2.1 Gene targeting table
    v1.2.2 DRAGON miRNA network
    v1.3 Network comparison
    v1.3.1 Guided tours
    v1.4.0 CCLE multi-omic map
    v1.5.0 EGRET networks
    v1.6.0 BONOBO networks
    v1.7.0 tcga-data-nf networks

    CHOL cancer networks

    Data sets 1 Networks Aggregate 1

    Hover over the bar plot to get the GO term. Differentially targeted genes and TFs were computed by comparing a cancer network to all other cancers.

    Tool description

    PANDA reconstructs a gene regulatory network using TF PPI, TF DNA binding motif, and gene expression samples. You can check the phenotypic information for the clinical variables of the samples that were used to reconstruct the network.
    The variable Samples indicates the number of samples used for network reconstruction. For single-sample networks, clicking the number of samples links to the phenotypic variable table and the individual networks. The number in the Sample variable and the phenotypic variable table may be different because the table can include samples from other studies. For example, in colon cancer, 444 TCGA samples were used to build LIONESS networks in a first study and 445 samples were used for a more recent study. The superset of both TCGA samples is comprised of 487 samples, which is the size of the pheotypic variables table. This discrepancy is due to different pre-processinng techniques, inclusion/exclusion criteria, and sample quality-control.

    Publication
    Please check the reference at the following link.
    # Tissue Tool netZoo release Network
    PPI
    Motif Expression Regulator nReg Genes Data Samples Precision
    Reference
    1 Cholangiocarcinoma PANDA netZooR 0.9
    AdjCodeVis
    TF 644 29375 TCGA 36 D

    Variable description

    This is a description of the primary clinical variables of the gene expression samples that were used to generate the gene regulatory network.

    Sample
    Gender Race Stage
    Vital status Age
    Days to last follow up Tumor ID
    TCGA-W5-AA36-01A FEMALE WHITE Stage IV Dead - [Not Available] CHOL
    TCGA-W5-AA2H-01A FEMALE WHITE Stage III Alive - 635 CHOL
    TCGA-WD-A7RX-01A FEMALE WHITE Stage II Dead - [Not Available] CHOL
    TCGA-3X-AAVC-01A FEMALE WHITE Stage I Alive - 371 CHOL
    TCGA-3X-AAVE-01A MALE ASIAN Stage II Alive - 203 CHOL
    TCGA-ZH-A8Y4-01A MALE WHITE Stage I Dead - [Not Available] CHOL
    TCGA-W5-AA2W-01A FEMALE WHITE Stage IVA Dead - [Not Available] CHOL
    TCGA-W5-AA2G-01A FEMALE WHITE Stage I Alive - 1976 CHOL
    TCGA-3X-AAVA-01A FEMALE WHITE Stage II Dead - [Not Available] CHOL
    TCGA-W5-AA2X-01A MALE WHITE Stage IVB Dead - [Not Available] CHOL
    TCGA-W5-AA2U-01A FEMALE WHITE Stage I Dead - [Not Available] CHOL
    TCGA-ZH-A8Y1-01A FEMALE WHITE Stage IVA Dead - [Not Available] CHOL
    TCGA-ZH-A8Y2-01A FEMALE BLACK OR AFRICAN AMERICAN Stage I Dead - [Not Available] CHOL
    TCGA-W5-AA30-01A MALE WHITE Stage I Alive - 1079 CHOL
    TCGA-W5-AA2T-01A FEMALE WHITE Stage II Dead - [Not Available] CHOL
    TCGA-3X-AAVB-01A FEMALE WHITE Stage IVB Alive - 368 CHOL
    TCGA-4G-AAZT-01A MALE WHITE Stage I Alive - 206 CHOL
    TCGA-W5-AA39-01A MALE WHITE Stage II Dead - [Not Available] CHOL
    TCGA-ZH-A8Y5-01A MALE WHITE Stage IVB Alive - 707 CHOL
    TCGA-W5-AA2Z-01A FEMALE WHITE Stage II Alive - 155 CHOL
    TCGA-ZU-A8S4-01A MALE WHITE Stage I Dead - [Not Available] CHOL
    TCGA-3X-AAV9-01A MALE ASIAN Stage I Dead - [Not Available] CHOL
    TCGA-ZH-A8Y8-01A MALE WHITE Stage I Alive - 104 CHOL
    TCGA-W5-AA2R-01A FEMALE WHITE Stage I Alive - 1485 CHOL
    TCGA-W5-AA31-01A MALE WHITE Stage I Alive - 10 CHOL
    TCGA-W5-AA2Q-01A MALE WHITE Stage II Alive - 50 CHOL
    TCGA-W5-AA38-01A FEMALE WHITE Stage I Alive - 964 CHOL
    TCGA-4G-AAZO-01A FEMALE WHITE Stage II Alive - 609 CHOL
    TCGA-ZD-A8I3-01A FEMALE ASIAN Stage II Alive - 0 CHOL
    TCGA-W5-AA2O-01A MALE WHITE Stage I Dead - [Not Available] CHOL
    TCGA-ZH-A8Y6-01A FEMALE BLACK OR AFRICAN AMERICAN Stage I Alive - 115 CHOL
    TCGA-W6-AA0S-01A FEMALE WHITE Stage I Alive - 352 CHOL
    TCGA-W5-AA33-01A MALE WHITE Stage I Alive - 1070 CHOL
    TCGA-YR-A95A-01A MALE WHITE Stage IV Dead - [Not Available] CHOL
    TCGA-W5-AA2I-01A MALE WHITE Stage I Dead - [Not Available] CHOL
    TCGA-W5-AA34-01A FEMALE WHITE Stage I Alive - 168 CHOL
    Sample Gender Race Stage Status Age Days to follow up Tumor ID
    Contact

    Department of Biostatistics
    Harvard T.H. Chan School of Public Health

    License
    Share